These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The inhibition of monoamine uptake into rat brain synaptosomess by selected bicyclo-octanes and an analogous bicyclo-octene. Wedley S, Howard JL, Large BT, Pullar IA. Biochem Pharmacol; 1978; 27(24):2907-9. PubMed ID: 736983 [No Abstract] [Full Text] [Related]
4. An inhibitor of dopamine uptake, LR5182, cis-3-(3,4-dichlorophenyl)-2-n,n-dimethylaminomethyl-bicyclo-[2,2,2]-octane, hydrochloride. Wong DT, Bymaster FP. Life Sci; 1978 Sep 11; 23(10):1041-7. PubMed ID: 713683 [No Abstract] [Full Text] [Related]
5. The effects of phencyclidine on the uptake of 3H-catecholamines by rat striatal and hypothalamic synaptosomes. Garey RE, Heath RG. Life Sci; 1976 May 15; 18(10):1105-10. PubMed ID: 933700 [No Abstract] [Full Text] [Related]
6. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo. Kafoe WF, Leonard BE. Biochem Pharmacol; 1977 Jun 01; 26(11):1083-4. PubMed ID: 880260 [No Abstract] [Full Text] [Related]
7. Preferential uptake of norepinephrine into dopaminergic terminals of a synaptosomal preparation from rat cerebral cortex. Michel M, Hiemke C, Ghraf R. Brain Res; 1984 May 28; 301(1):149-52. PubMed ID: 6329439 [Abstract] [Full Text] [Related]
8. The isomers of cocaine and tropacocaine: effect on 3H-catecholamine uptake by rat brain synaptosomes. Komiskey HL, Miller DD, LaPidus JB, Patil PN. Life Sci; 1977 Oct 15; 21(8):1117-22. PubMed ID: 916808 [No Abstract] [Full Text] [Related]
9. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Bolden-Watson C, Richelson E. Life Sci; 1993 Oct 15; 52(12):1023-9. PubMed ID: 8445992 [Abstract] [Full Text] [Related]
10. Mepiprazole, a new psychotropic drug: effects on uptake and retention of monoamines in rat brain synaptosomes. Placheta P, Singer E, Kriwanek W, Hertting G. Psychopharmacology (Berl); 1976 Aug 17; 48(3):295-301. PubMed ID: 9660 [Abstract] [Full Text] [Related]
12. Release of biogenic amines from isolated nerve endings. Raiteri M, Bertollini A, del Carmine R, Levi G. Adv Exp Med Biol; 1976 Aug 17; 69():319-35. PubMed ID: 941741 [No Abstract] [Full Text] [Related]
14. Studies on 4-(p-bromophenyl)-bicyclo (2,2,2) octan-1-amine as an inhibitor of uptake into serotonin neurones. Fuller RW, Snoddy HD, Perry KW, Bymaster FP, Wong DT. Neuropharmacology; 1978 Oct 17; 17(10):815-8. PubMed ID: 745679 [No Abstract] [Full Text] [Related]
15. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice. Efthimiopoulos S, Giompres P, Valcana T. J Neurosci Res; 1991 Aug 17; 29(4):510-9. PubMed ID: 1838778 [Abstract] [Full Text] [Related]
16. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine. Horn AS, Snyder SH. J Pharmacol Exp Ther; 1972 Mar 17; 180(3):523-30. PubMed ID: 5012779 [No Abstract] [Full Text] [Related]
18. Blockade of monoamine uptake by 1-amino-4-phenylbicyclo(2,2,2)octane (EXP 561) in rat brain and heart. Wong DT, Molloy BB, Bymaster FP. Neuropharmacology; 1977 Jan 17; 16(1):11-5. PubMed ID: 834358 [No Abstract] [Full Text] [Related]
20. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain. Steele TD, Nichols DE, Yim GK. Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]